세계의 REBOA(Resuscitative Endovascular Balloon Occlusion of the Aorta) 시장

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market to Reach US$37.2 Million by 2030

The global market for Resuscitative Endovascular Balloon Occlusion of the Aorta estimated at US$12.5 Million in the year 2024, is expected to reach US$37.2 Million by 2030, growing at a CAGR of 20.0% over the analysis period 2024-2030. Cardiac Arrest, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$21.7 Million by the end of the analysis period. Growth in the Aortic Occlusion segment is estimated at 23.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Million While China is Forecast to Grow at 19.0% CAGR

The Resuscitative Endovascular Balloon Occlusion of the Aorta market in the U.S. is estimated at US$3.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Million by the year 2030 trailing a CAGR of 19.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.1% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 14.9% CAGR.

Global Resuscitative Endovascular Balloon Occlusion of the Aorta Market - Key Trends & Drivers Summarized

Why Is Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) Gaining Widespread Adoption in Trauma Care?

Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as a life-saving intervention for trauma patients experiencing hemorrhagic shock due to severe abdominal, pelvic, or lower extremity injuries. Traditionally, uncontrolled bleeding in such cases has been managed through immediate open surgery, but REBOA offers a minimally invasive alternative that improves survival rates by temporarily controlling hemorrhage and stabilizing patients until definitive surgical treatment can be performed. The increasing incidence of traumatic injuries from road accidents, battlefield injuries, and industrial accidents has driven the demand for REBOA procedures in emergency and military medicine. Additionally, advancements in vascular access technology have made the procedure more accessible, increasing its adoption across trauma centers and pre-hospital care settings.

How Are Technological Innovations Enhancing the Efficiency and Safety of REBOA?

Innovations in catheter-based interventions and endovascular technology have significantly improved the efficacy and safety of REBOA procedures. The development of smaller, lower-profile balloon catheters has reduced complications associated with vascular access and prolonged occlusion times. Additionally, real-time imaging guidance and pressure monitoring systems are enabling more precise placement and inflation of the balloon, minimizing the risk of ischemic injury. Automated REBOA systems with wireless monitoring capabilities are also being explored, allowing clinicians to remotely adjust occlusion levels and optimize perfusion control. These technological advancements are making REBOA a more viable and safer option for trauma management, expanding its clinical applications beyond traditional emergency settings.

What Market Trends Are Driving the Expansion of the REBOA Market?

The growing emphasis on improving trauma care infrastructure has led to increased adoption of REBOA in both civilian and military healthcare settings. The integration of REBOA into pre-hospital emergency services, including ambulance and air-medical transport units, is further expanding its reach. Additionally, medical institutions are investing in REBOA training programs to equip trauma surgeons, emergency physicians, and critical care teams with the necessary skills to perform the procedure effectively. The rise of hybrid operating rooms and endovascular trauma management protocols has also facilitated the wider adoption of REBOA in tertiary care centers. Moreover, government funding and research initiatives aimed at reducing mortality from traumatic injuries are supporting the market's growth.

What Are the Key Growth Drivers of the REBOA Market?

The growth in the global REBOA market is driven by increasing trauma-related fatalities, advancements in endovascular balloon occlusion technology, and the expansion of emergency trauma care infrastructure. The adoption of minimally invasive life-saving procedures, particularly in military and civilian trauma centers, has further accelerated demand. Additionally, ongoing clinical research into optimizing REBOA techniques and expanding its applications in non-trauma conditions, such as postpartum hemorrhage, is broadening its market potential. The integration of AI-powered monitoring systems and robotic-assisted vascular procedures is also expected to enhance the precision and safety of REBOA, fueling market expansion. As healthcare systems prioritize rapid intervention strategies for trauma patients, the REBOA market is poised for substantial growth, revolutionizing the field of emergency medicine.

SCOPE OF STUDY:

The report analyzes the Resuscitative Endovascular Balloon Occlusion of the Aorta market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Cardiac Arrest, Aortic Occlusion, Tactical Combat Casualty Care)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

• Abbott Laboratories
• Acandis GmbH
• AngioDynamics, Inc.
• Asahi Kasei Corporation
• Bentley InnoMed GmbH
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• BVM Medical Limited
• Cardinal Health, Inc.
• Cook Medical
• Edwards Lifesciences Corporation
• Emergency Scientific, LLC
• Front Line Medical Technologies
• Johnson & Johnson
• Lepu Medical Technology
• Medtronic plc
• Merit Medical Systems, Inc.
• Mermaid Medical Group
• MicroPort Scientific Corporation
• Oscor Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Resuscitative Endovascular Balloon Occlusion of the Aorta - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Traumatic Hemorrhage and Non-Compressible Bleeding Conditions Drives REBOA Adoption
  • Increased Recognition of REBOA as a Life-Saving Pre-Hospital and Emergency Room Intervention Spurs Clinical Uptake
  • Technological Advancements in Balloon Catheter Design Enhance Ease of Deployment and Procedural Speed
  • Expansion of Trauma and Acute Care Surgery Programs Throws the Spotlight on Endovascular Resuscitation Devices
  • Surge in Combat and Military Applications Strengthens Business Case for REBOA in Battlefield Medicine
  • Regulatory Approvals for Low-Profile and Partial Occlusion Devices Expand Indication Spectrum
  • Growth in Emergency Medicine Residency Training Supports Familiarity and Usage of REBOA Systems
  • Integration of REBOA in Trauma Protocols and ATLS Guidelines Drives Hospital Adoption Rates
  • Increased Utilization in Obstetric Hemorrhage and Ruptured Aneurysm Cases Expands Off-Label Applications
  • Development of Zone-Specific Occlusion Strategies Enhances Targeted Hemodynamic Stabilization
  • Partnerships Between Device Manufacturers and Trauma Centers Accelerate Product Validation and Usage
  • Surging Demand for Hemorrhage Control in Civilian Mass Casualty Incidents Fuels Device Availability
  • Adoption of Portable and Ultrasound-Guided REBOA Techniques Expands Pre-Hospital Intervention Capabilities
  • OEM Investment in Simulation-Based Training Programs Promotes Safe Implementation Across Institutions
  • Rising Emphasis on Damage Control Resuscitation Supports Complementary Role of REBOA With Surgical Interventions
  • Improved Data From Prospective Trials Strengthens Clinical Confidence and Inclusion in Guidelines
  • Use of REBOA in Hybrid Operating Rooms and Angio Suites Increases Workflow Integration
  • Focus on Reducing Time-to-Intervention and Transport-Related Mortality Drives REBOA Training Among Paramedics
  • Global Expansion of Advanced Trauma Systems Opens Market for REBOA in Developing Countries
  • Adoption of Balloon Occlusion Techniques in Non-Traumatic Hemorrhagic Shock Supports Expanded Utility
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Resuscitative Endovascular Balloon Occlusion of the Aorta Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac Arrest by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 5: World 6-Year Perspective for Cardiac Arrest by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for Aortic Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 7: World 6-Year Perspective for Aortic Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Tactical Combat Casualty Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World 6-Year Perspective for Tactical Combat Casualty Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 10: USA Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 11: USA 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• CANADA
  • TABLE 12: Canada Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 13: Canada 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• JAPAN
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 14: Japan Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 15: Japan 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• CHINA
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 16: China Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 17: China 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• EUROPE
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 18: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 19: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • TABLE 20: Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 21: Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• FRANCE
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 22: France Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 23: France 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• GERMANY
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 24: Germany Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 25: Germany 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• ITALY
  • TABLE 26: Italy Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Italy 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• UNITED KINGDOM
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 28: UK Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 29: UK 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• REST OF EUROPE
  • TABLE 30: Rest of Europe Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 31: Rest of Europe 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• ASIA-PACIFIC
  • Resuscitative Endovascular Balloon Occlusion of the Aorta Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 32: Asia-Pacific Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 33: Asia-Pacific 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030
• REST OF WORLD
  • TABLE 34: Rest of World Recent Past, Current & Future Analysis for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 35: Rest of World 6-Year Perspective for Resuscitative Endovascular Balloon Occlusion of the Aorta by End-Use - Percentage Breakdown of Value Sales for Cardiac Arrest, Aortic Occlusion and Tactical Combat Casualty Care for the Years 2025 & 2030

IV. COMPETITION